E-LIB Suche - Ergebnisse für: Hantel, Stefan

1

Effect of Qualifying Atherosclerotic Cardiovascular Disease..:

Odutayo, Ayodele ; Zinman, Bernard ; Wanner, Christoph...
CJC Open. 6 (2024) 7 - p. 868-875 , 2024

2

Impact of empagliflozin on first and recurrent events leadi..:

Inzucchi, Silvio E. ; Wanner, Christoph ; Fitchett, David...
Diabetes Research and Clinical Practice. 212 (2024) - p. 111715 , 2024

Link: https://doi.org/10.1016/..

3

How do SGLT2 inhibitors protect the kidney? A mediation ana..:

Wanner, Christoph ; Nangaku, Masaomi ; Kraus, Bettina J...
Nephrology Dialysis Transplantation. , 2024

Link: https://doi.org/10.1093/..

4

Empagliflozin and Rapid Kidney Function Decline Incidence i..:

Hadjadj, Samy ; Cooper, Mark E. ; Steubl, Dominik...
Kidney Medicine. 6 (2024) 3 - p. 100783 , 2024

Link: https://doi.org/10.1016/..

5

Nephrotic-range proteinuria in type 2 diabetes: Effects of ..:

Ruggenenti, Piero ; Kraus, Bettina J. ; Inzucchi, Silvio E....
eClinicalMedicine. 43 (2022) - p. 101240 , 2022

Link: https://doi.org/10.1016/..

6

Mediators of the improvement in heart failure outcomes with..:

Fitchett, David ; Inzucchi, Silvio E. ; Zinman, Bernard...
ESC Heart Failure. 8 (2021) 6 - p. 4517-4527 , 2021

Link: https://doi.org/10.1002/..

7

Patient Phenotypes and SGLT-2 Inhibition in Type 2 Diabetes:

Sharma, Abhinav ; Ofstad, Anne Pernille ; Ahmad, Tariq...
JACC: Heart Failure. 9 (2021) 8 - p. 568-577 , 2021

Link: https://doi.org/10.1016/..

8

Designing, Conducting, Monitoring, and Analyzing Data from ..:

Lentz, Trevor A. ; Curtis, Lesley H. ; Rockhold, Frank W....
Therapeutic Innovation & Regulatory Science. 54 (2020) 6 - p. 1477-1488 , 2020

Link: https://doi.org/10.1007/..

9

Cardiovascular outcomes and LDL-cholesterol levels in EMPA-..:

Langslet, Gisle ; Zinman, Bernard ; Wanner, Christoph...
Diabetes and Vascular Disease Research. 17 (2020) 6 - p. 147916412097525 , 2020

Link: https://doi.org/10.1177/..

10

Are the cardiovascular and kidney benefits of empagliflozin..:

Inzucchi, Silvio E. ; Fitchett, David ; Jurišić‐Eržen, Dubravka...
Diabetes, Obesity and Metabolism. 22 (2020) 4 - p. 631-639 , 2020

Link: https://doi.org/10.1111/..

11

Empagliflozin and kidney outcomes in Asian patients with ty..:

Kadowaki, Takashi ; Nangaku, Masaomi ; Hantel, Stefan...
Journal of Diabetes Investigation. 10 (2019) 3 - p. 760-770 , 2019

Link: https://doi.org/10.1111/..

12

Glucose Control and the Effect of Empagliflozin on Kidney O..:

Cooper, Mark E. ; Inzucchi, Silvio E. ; Zinman, Bernard...
American Journal of Kidney Diseases. 74 (2019) 5 - p. 713-715 , 2019

Link: https://doi.org/10.1053/..

13

Restricted mean survival time for the analysis of cardiovas..:

Manner, David H. ; Battioui, Chakib ; Hantel, Stefan...
American Heart Journal. 215 (2019) - p. 178-186 , 2019

Link: https://doi.org/10.1016/..

14

Efficacy and safety of empagliflozin in older patients in t..:

Monteiro, Pedro ; Bergenstal, Richard M ; Toural, Elvira...
Age and Ageing. 48 (2019) 6 - p. 859-866 , 2019

Link: https://doi.org/10.1093/..

15

Empagliflozin is associated with improvements in liver enzy..:

Sattar, Naveed ; Fitchett, David ; Hantel, Stefan..
Diabetologia. 61 (2018) 10 - p. 2155-2163 , 2018

Link: https://doi.org/10.1007/..